Physician profile
Barry Buffman
NPI 1356480016
$5,064.15
in general payments reported to CMS, 2019-2025
38 companies · $946 in 2025
The $946 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $793 · 2020: $163 · 2021: $246 · 2022: $246 · 2023: $1,593 · 2024: $1,076 · 2025: $946.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,616.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,615.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $1,393.09 | 2019-2025 | Airsupra, Breztri, Farxiga |
| Novo Nordisk INC | $645.63 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Irhythm Technologies, INC. | $335.76 | 2022-2024 | Zio Xt Patch, Zio Monitor |
| Boehringer Ingelheim Pharmaceuticals, INC. | $307.51 | 2019-2025 | Jardiance |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $261.55 | 2019 | |
| Glaxosmithkline, LLC. | $236.11 | 2019-2024 | Arexvy, Trelegy Ellipta |
| Lilly USA, LLC | $224.82 | 2019-2025 | Jardiance, Mounjaro |
| Bayer Healthcare Pharmaceuticals INC. | $205.29 | 2023-2024 | |
| Merck Sharp & Dohme LLC | $180.95 | 2019-2023 | Verquvo, Belsomra |
| Amgen INC. | $178.45 | 2019 | |
| Pfizer INC. | $174.00 | 2023-2025 | |
| Gilead Sciences, INC. | $125.00 | 2023 | Epclusa |
| Dexcom, INC. | $124.14 | 2024-2025 | Dexcom G6 Transmitter |
| Abbvie INC. | $123.12 | 2023 | Linzess |
| Stryker Corporation | $70.94 | 2024 | Insignia |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vision Quest Industries INC. | $41.05 | 2022-2024 | Oactive Align Custom R |
| Eisai INC. | $36.34 | 2020-2021 | |
| Novartis Pharmaceuticals Corporation | $33.21 | 2019 | |
| Biohaven Pharmaceuticals, INC. | $29.86 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $26.93 | 2025 | Dupixent |
| Corcept Therapeutics | $26.61 | 2025 | Korlym |
| Vertiflex, INC. | $24.74 | 2019 | |
| Philips North America LLC | $24.34 | 2022 | |
| Exact Sciences Corporation | $24.20 | 2025 | Cologuard Collection Kit |
| Endo Pharmaceuticals INC. | $23.49 | 2022 | |
| Amarin Pharma, INC. | $23.08 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $19.83 | 2025 | Zoryve |
| Grifols USA, LLC | $18.23 | 2019 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $16.58 | 2022 | |
| Therapeuticsmd, INC. | $16.56 | 2019 | |
| Lundbeck LLC | $15.89 | 2025 | Rexulti |
| Hologic Sales and Service, LLC | $15.19 | 2022 | |
| Smith+Nephew, INC. | $13.43 | 2023 | Collagenase Santyl |
| Sanofi Pasteur INC. | $12.72 | 2019 | |
| Zyla Life Sciences, INC. | $12.06 | 2019 | |
| Arbor Pharmaceuticals, INC. | $11.92 | 2019 | |
| Xeris Pharmaceuticals, INC. | $11.53 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Barry Buffman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.